Ilkos Therapeutics Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Ilkos Therapeutics Inc. - overview
Established
2016
Location
Laval, QC-Quebec, Canada
Primary Industry
Biotechnology
About
Established in 2016 and based in Laval, Quebec, Ilkos Therapeutics Inc. is a biotechnology company that develops oral treatment for venous lower limb ulcers.
Current Investors
Fonds de Solidarité des Travailleurs du Québec, CTI Life Sciences, Servier Canada Inc.
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy
Company Stage
Early Stage
Total Amount Raised
Subscriber access only
Ilkos Therapeutics Inc. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Unspecified Round | Completed | Ilkos Therapeutics Inc. | - |
Displaying 1 - 1 of 1
Ilkos Therapeutics Inc. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.